[go: up one dir, main page]

PL1819354T3 - Sposoby i związki do leczenia cukrzycy - Google Patents

Sposoby i związki do leczenia cukrzycy

Info

Publication number
PL1819354T3
PL1819354T3 PL05791454T PL05791454T PL1819354T3 PL 1819354 T3 PL1819354 T3 PL 1819354T3 PL 05791454 T PL05791454 T PL 05791454T PL 05791454 T PL05791454 T PL 05791454T PL 1819354 T3 PL1819354 T3 PL 1819354T3
Authority
PL
Poland
Prior art keywords
compounds
methods
treating diabetes
diabetes
treating
Prior art date
Application number
PL05791454T
Other languages
English (en)
Inventor
Per Olof Berggren
Lisa-Juntti Berggren
Original Assignee
Biocrine Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrine Ab filed Critical Biocrine Ab
Publication of PL1819354T3 publication Critical patent/PL1819354T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PL05791454T 2004-08-26 2005-08-26 Sposoby i związki do leczenia cukrzycy PL1819354T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60479204P 2004-08-26 2004-08-26
EP05791454A EP1819354B1 (en) 2004-08-26 2005-08-26 Methods and compounds for treating diabetes
PCT/EP2005/009238 WO2006021451A2 (en) 2004-08-26 2005-08-26 Methods and compounds for treating diabetes

Publications (1)

Publication Number Publication Date
PL1819354T3 true PL1819354T3 (pl) 2011-12-30

Family

ID=35694660

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05791454T PL1819354T3 (pl) 2004-08-26 2005-08-26 Sposoby i związki do leczenia cukrzycy

Country Status (6)

Country Link
EP (1) EP1819354B1 (pl)
AT (1) ATE516813T1 (pl)
DK (1) DK1819354T3 (pl)
ES (1) ES2369919T3 (pl)
PL (1) PL1819354T3 (pl)
WO (1) WO2006021451A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ540597A (en) * 2005-06-08 2007-02-23 Neurotrophincell Pty Ltd A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells
WO2007111938A2 (en) 2006-03-23 2007-10-04 The General Hospital Corporation Inflammation-inhibitory serum factors and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100457122C (zh) * 2002-05-14 2009-02-04 尼普洛株式会社 包含三价铬离子的化合物在制备用于预防和/或治疗淀粉样变性的药物的应用
CN101413143B (zh) * 2002-12-19 2013-09-18 斯克里普斯研究学院 稳定甲状腺素运载蛋白和抑制甲状腺素运载蛋白错折叠的组合物和方法

Also Published As

Publication number Publication date
EP1819354B1 (en) 2011-07-20
EP1819354A2 (en) 2007-08-22
WO2006021451A3 (en) 2006-04-13
DK1819354T3 (da) 2011-09-12
ES2369919T3 (es) 2011-12-09
ATE516813T1 (de) 2011-08-15
WO2006021451A2 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
TW200608961A (en) Methods and reagents for the treatment of metabolic disorders
TW200716141A (en) Compositions and methods for treatment for neoplasms
TW200714283A (en) Method and composition for treating peripheral vascular diseases
MX2009009738A (es) Tratamiento de degeneracion macular relacionada con la edad usando inhibidores de factor d de complemento.
MX2009012625A (es) Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21.
WO2007081720A3 (en) Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
WO2007016548A3 (en) Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
TW200738270A (en) Method of treating depression using a TNFα antibody
IL200120A0 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
MX2008011185A (es) Marcadores para adiccion.
WO2005117938A3 (en) Methods of treating ocular conditions
MX2010000956A (es) Derivados de isoftalamida que inhiben actividad de beta-secretasa.
HK1115528A1 (en) Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases
TW200740460A (en) Pharmaceutical composition containing PPAR γ agonist
WO2009042642A3 (en) Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer
MX2009009693A (es) Metodos para activar irs-1 y akt.
TW200716579A (en) Novel chemical compounds
PL1819354T3 (pl) Sposoby i związki do leczenia cukrzycy
WO2010065085A3 (en) Methods and compositions for treating or preventing pruritis
WO2007064997A3 (en) Compounds and methods for inhibiting apoptosis
TW200714284A (en) Novel method
WO2006078776A3 (en) Inhibitors and methods of treatment of cardiovascular diseases, and methods for identifying inhibitors
HK1060883A1 (en) Chemical compounds.
BG110157A (en) INDONAL COMPOUNDS USE FOR TREATMENT OF DISABILITY OF KNOWLEDGE COMPETENCE